|MDACC Study No:||ID02-040 (clinicaltrials.gov NCT No: NCT00068575)|
|Title:||A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined with Radiation Treatment for Patients with Resected Pancreatic Adenocarcinoma|
|Principal Investigator:||Peter W. Pisters|
|Treatment Agent:||Interferon Alpha-2B; Radiation|
|Study Description:||The goal of this clinical research study is to learn if the combination of |
5-fluorouracil (5-FU), cisplatin, and interferon alfa-2b (Intron-A), given with
radiation treatment, can help to prevent the growth of cancers in the
pancreas. The safety of this combination treatment will also be studied.